Elodie Moysan
Inserm(FR)Université Nantes Angers Le Mans(FR)Centre Hospitalier Universitaire d'Angers(FR)Micro et Nanomédecines translationnelles
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Cancer, Hypoxia, and Metabolism, Advancements in Transdermal Drug Delivery, Nanoplatforms for cancer theranostics, Cancer Treatment and Pharmacology
Most-Cited Works
- → Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications(2012)216 cited
- → Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin(2010)135 cited
- → An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure(2013)50 cited
- → Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice(2015)30 cited
- Lauroyl-gemcitabine loaded lipid nanocapsules for the treatment of metastases in mediastinal lymph nodes(2014)
- An original nanomedicine to deliver gemcitabine in lymph nodes invaded by metastasis(2012)
- Innovative gel formulation of lipid nanocapsules with modified gemcitabine: a new pharmaceutical technology for lung and pancreatic cancer therapy(2012)
- Hydrogel de nanocapsules lipidiques chargées en gemcitabine : une technologie pharmaceutique pour cibler les ganglions de drainage des cancers(2013)